David Ajibade

David Ajibade possesses extensive experience in clinical research, with a career spanning multiple organizations since 2014. Starting as a Clinical Research Coordinator at Atlus Houston Hospital, David transitioned to roles at ICON plc, Legend Biotech, and Immunocore, where responsibilities included leading the execution of clinical studies and ensuring compliance with regulatory standards. As a Clinical Research Associate at ICON plc, David achieved a 95% on-time completion rate for clinical studies. At Legend Biotech, David maintained 100% compliance with regulatory guidelines while managing over 10 clinical studies. Currently, as a Principal Clinical Research Associate at Pfizer, David oversees Phase I-IV clinical studies, ensuring adherence to protocols and serving as the main contact for clinical sites. David's focus on site management and patient recruitment strategies has consistently contributed to meeting study objectives.